NASDAQ · Drug Manufacturers - Specialty & Generic

SNOA (SNOA) Stock

$1.20 +7.14% NASDAQ: SNOA Healthcare

Valuation

MetricValue
Price$1.20
Market Cap$2.02M
P/E Ratio-0.38
P/B Ratio0.46
P/S Ratio0.10
EPS (TTM)$-2.79
52-Week High$6.92
52-Week Low$0.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-75.00%
ROA-21.43%
ROCE-80.00%
Gross Margin-28.57%
Operating Margin-28.57%
Net Margin-19.02%
Debt/Equity0.19
Current Ratio3.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$19.0M$13.0M$13.0M$13.0M$14.0M
Operating Profit$-3.0M$-6.0M$-5.0M$-5.0M$-4.0M
Net Profit$-4.0M$-5.0M$-5.0M$-5.0M$-3.0M
EPS$-23.65$-19.17$-15.18$-5.32$-2.79
Op Margin-18.5%-46.6%-34.4%-36.9%-26.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$15.0M$19.0M$16.0M$15.0M$14.0M
Total Liabilities$10.0M$10.0M$8.0M$9.0M$9.0M
Cash$4.0M$7.0M$4.0M$3.0M$5.0M
Borrowings$3.0M$1.0M$1.0M$1.0M$0

Latest News

Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options MT Newswires · Jun 30, 2026 Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution ACCESS Newswire · Jun 30, 2026 Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results ACCESS Newswire · Jun 16, 2026 Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering ACCESS Newswire · Apr 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-4.0M$-6.0M$-2.0M$0
Investing Cash Flow$0$0$-1.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$3.0M$-4.0M$-1.0M$2.0M
Free Cash Flow$-4.0M$-4.0M$-6.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-136.90%
Quick Ratio2.00
Interest Coverage—
Return 1Y-66.85%
Return 3Y-94.70%
Return 5Y-99.01%

Ownership

Insiders Held0.42%
Institutions Held1.43%
Institutions Float Held1.43%
Institutional HolderSharesReport Date
Geode Capital Management, LLC19,9412026-03-31
Vanguard Capital Management LLC18,7872026-03-31
DRW Securities, LLC12,0152026-03-31
McKinley Carter Wealth Services, Inc.11,1932026-03-31
Morgan Stanley2,0042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BFRI $1.17 -4.88% -0.90 $14.98M 0.00%
CPHI $1.11 -14.62% -0.87 $3.53M 0.00%
EVOKEvoke Pharma, Inc. $11.00 +0.00% -6.96 $18.95M 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
MYNZMainz Biomed B.V. $3.59 +0.84% -2.93 $14.69M 0.00%

About SNOA

SNOA is led by CEO Amy Trombly, employs 10 people, headquartered in US, publicly traded since 2007.

SNOA stock trades at $1.20 with a market capitalization of $2.02M. The stock is valued at a price-to-earnings (P/E) ratio of -0.38, price-to-book of 0.46, price-to-sales of 0.10. Over the past 52 weeks the stock has ranged between $0.85 and $6.92, and currently trades 82.7% below its 52-week high.

On profitability, SNOA generates a return on equity (ROE) of -75.00%, return on capital employed of -80.00%, an operating margin of -28.57%, a net profit margin of -19.02%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides